This HTML5 document contains 159 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n10http://dx.doi.org/10.1186/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12https://scigraph.springernature.com/pub.10.1186/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37400113
rdf:type
wikibase:Item
schema:description
article scientifique vetenskaplig artikel article científic scientific article published on 10 December 2013 vědecký článek artigo científico bilimsel makale articolo scientifico 2013 թվականի դեկտեմբերի 10-ին հրատարակված գիտական հոդված artículu científicu espublizáu en 2013 videnskabelig artikel vedecký článok wissenschaftlicher Artikel wetenschappelijk artikel наукова стаття, опублікована в грудні 2013 научни чланак مقالة علمية نشرت في 10 ديسمبر 2013
p:P577
wds:Q37400113-D3D1D507-3C7C-4133-8373-4521D3EC335B
wdt:P577
2013-12-10T00:00:00Z
p:P2888
wds:Q37400113-4ED1CFCA-E2C9-4795-8A52-3AED7005BB9B
wdt:P2888
n12:2045-3329-3-15
p:P2860
wds:Q37400113-898B74F4-C8EF-4E34-B5C2-E87128809F17 wds:Q37400113-8EDF0A0F-6ADE-498A-AFA7-F773220F92C3 wds:Q37400113-9948A248-74F4-43B4-88B6-41EE56A4446A wds:Q37400113-6803ECAF-621C-444F-A211-02A4453D04A4 wds:Q37400113-6FBBC28C-D7AF-4C03-B2AF-84904D0F30EB wds:Q37400113-75556D50-BFE0-4719-8D9E-3AC079A5F2D9 wds:Q37400113-801B9E51-A7A8-4701-80E2-602216521EC0 wds:Q37400113-80913050-9464-4C32-95D0-36523C99AD2C wds:Q37400113-B8C851CE-AD6C-498C-BEC0-221255C9B43B wds:Q37400113-BDD68BA3-D57E-4E6D-B60F-DBDCAD655296 wds:Q37400113-C125C31C-55C9-4484-B5F4-F59A2CD68B5D wds:Q37400113-CD2758A1-F7B8-4B90-93FC-FE0D8CF5D94B wds:Q37400113-9B0FE906-51A3-4582-85B6-0C5624ED9658 wds:Q37400113-9B5F9F10-D14F-4479-9430-B32572CFA443 wds:Q37400113-9BC4EC90-6E5D-4C59-83B9-1E37DB0D1501 wds:Q37400113-9BF52A25-D137-4C22-A08C-B07EF7FE7FB4 wds:Q37400113-9C873144-29F4-4DA3-A9EE-3CB5AE371359 wds:Q37400113-9EFAC52A-9363-4D20-94C5-1B66A578C9F8 wds:Q37400113-AAFDE5B1-D435-46D7-B213-B7AB17FA3799 wds:Q37400113-AF0FF37F-3A29-4630-AC17-015D0D78430E wds:Q37400113-F4AF4B72-E5E7-462F-908A-325DF5111352 wds:Q37400113-D9DFF28C-A5CA-4FE5-B599-4CBDD3C82952 wds:Q37400113-DE8B5FC2-7D31-4E82-AC1D-F0114207090D wds:Q37400113-E15C259A-6737-47C6-AE61-68F27E3084E5 wds:Q37400113-E51BEED7-8DC2-445F-8F8D-AFC912F0FC79 wds:Q37400113-E9AF1EDC-4616-41DC-A134-880D96C456C6 wds:Q37400113-EF0E3541-0C4C-4277-A055-47951AD67B8E wds:Q37400113-F2BC4CEB-6EBE-4B3D-A4DA-2F2614E71E3D wds:Q37400113-00B4DF5C-FCD8-44F5-A922-571633D8806E wds:Q37400113-098EA2EC-8BE1-4D5C-9E86-7380000D67F6 wds:Q37400113-161503B8-3006-4794-B662-1BFF3020B145 wds:Q37400113-2412B9C4-2DB0-4F06-B8CE-617F9FD5D8F9 wds:Q37400113-2B883D80-F03A-4CAC-BDE7-19A95B12CD39 wds:Q37400113-614444D1-E089-4E03-9127-2BFE690209CF wds:Q37400113-30024404-8AA6-44E1-B77E-91FFB4BB3B3E wds:Q37400113-396C2D2C-45CE-4355-B3C4-2BB0E23A7055 wds:Q37400113-3C57C073-FB19-4D72-9314-FE5401D0D60C wds:Q37400113-411E12AD-1954-4C40-9D84-6B6FA6BB79B0 wds:Q37400113-42816C83-9849-4A48-A130-4005421B922A wds:Q37400113-4322CD43-61A3-4180-9551-450D9C3F26D1 wds:Q37400113-4BA43951-0525-44D8-A191-D8971B9E5A7C wds:Q37400113-82D2F7D9-7BB5-44B1-88EB-D0F39235C91D
wdt:P2860
wd:Q44320806 wd:Q33994512 wd:Q34533734 wd:Q51137797 wd:Q53231062 wd:Q81132586 wd:Q77761715 wd:Q34053786 wd:Q35848771 wd:Q83019278 wd:Q45999728 wd:Q67244298 wd:Q68489640 wd:Q34529891 wd:Q33384413 wd:Q40383826 wd:Q35629092 wd:Q67522321 wd:Q41123160 wd:Q37198992 wd:Q30497854 wd:Q59377137 wd:Q71730035 wd:Q36961822 wd:Q33396263 wd:Q82884131 wd:Q46215445 wd:Q44583963 wd:Q34912405 wd:Q69055787 wd:Q37894250 wd:Q43543641 wd:Q56391087 wd:Q64211545 wd:Q42561950 wd:Q33407709 wd:Q37114564 wd:Q24642872 wd:Q73603372 wd:Q77562044 wd:Q40318247 wd:Q77579162
p:P2093
wds:Q37400113-DA92A92B-CAB3-485B-80EA-3D86FEEADB03 wds:Q37400113-C976DC3A-22C8-45AE-818A-458C7CF29A60 wds:Q37400113-C6CFC57D-4408-4CC6-8B98-E3FB0F3C3597 wds:Q37400113-94179583-4E71-4B8E-A501-B8A194BB32DC wds:Q37400113-7066B434-95F3-4D1F-802A-508DFB307845 wds:Q37400113-660C6436-8639-4B7D-AB4E-9F8055015A11 wds:Q37400113-5B3F12A7-A3CB-40BA-A284-484D70F89980
wdt:P2093
Marnie Collins Samantha Wieringa Senthil Lingaratnam Jayesh Desai Lisa Orme Jeremy Lewin David M Thomas
rdfs:label
Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review
skos:prefLabel
Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review
schema:name
Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review
p:P1476
wds:Q37400113-5C15EE33-AF54-4435-94D1-7AF287DB5527
wdt:P1476
Intra-patient dose escalation in Ewing's sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review
p:P304
wds:Q37400113-FA3C206F-1A15-4A01-90D1-8BD4664EE989
wdt:P304
15
p:P31
wds:Q37400113-8865D07E-5AF7-4922-8DF3-2E20FB410ECB
wdt:P31
wd:Q13442814
p:P921
wds:Q37400113-0D3F27BA-E4AA-49C7-81C6-B18A751A306F wds:Q37400113-51B3F777-CBE6-4122-889A-934FC1D82F96 wds:Q37400113-7556BE40-572C-4AC9-9033-33554D7A1714
wdt:P921
wd:Q418560 wd:Q18936 wd:Q418817
p:P698
wds:Q37400113-510EE40A-816A-4034-8438-4ABADBC777CB
wdtn:P698
n13:24321600
wdt:P698
24321600
p:P1433
wds:Q37400113-42693717-F63B-439A-836D-44EB06F0867D
wdt:P1433
wd:Q27724025
p:P433
wds:Q37400113-9A8280FE-89E7-4398-BFEF-8F37398DC345
p:P478
wds:Q37400113-71B5E310-3E90-4ABF-9550-0D3697B9232E
wdt:P433
1
wdt:P478
3
p:P356
wds:Q37400113-0F8020C7-2C54-4102-A5D3-89C5C1AEAAD0
wdtn:P356
n10:2045-3329-3-15
wdt:P356
10.1186/2045-3329-3-15
p:P5875
wds:Q37400113-CC4A506F-380D-44A0-A9A0-1859C096FAE3
wdt:P5875
259252126
p:P6179
wds:Q37400113-4E6828FB-625C-4CCC-B5B9-02496B749316
wdt:P6179
1022482370
p:P932
wds:Q37400113-86BBC667-46E0-48B2-A34E-316E7D149E6A
wdt:P932
3866566